Benelux
Optimism prevails as PEs expect step-up in deal-making – research
Third Bridge's Joshua Maxey speaks to Unquote about the findings of the Mid-market PE Forecast: 2022
PE fundraising pipeline offers hope amidst slowdown in H1 2022
Final closes down by almost half so far this year, but a number of "mega-cap" vehicles in coming months could still bolster 2022 fundraising
Bain Capital appoints advisers for Bugaboo exit
Dutch pram maker to hit the M&A pipeline in an auction guided by Baird and Barclays Capital
Cinven holds EUR 1.5bn final close for financial services fund
GP's first sector-focused fund has made three deals, the first of which was insurance broker Miller
Corporates best placed for autumn IPO window as sponsors sit out
GPs expected to continue to ditch listings in the short term in favour of sale exits, longer holding periods
Curiosity VC eyes EUR 75m fund close in 2023
Dutch investor has commitments from 55 LPs for fund launched last year
Unigestion holds EUR 900m final close for fifth secondaries fund
Fund is more than three times the size of its predecessor and is more than 50% committed
Deft deployment, creative exits drive PE agenda into H2 2022
Take-privates, bolt-on opportunities and demand for resilient healthcare and technology assets offer hope for challenging second half of the year
Levine Leichtman Capital appoints head of Europe
Promotion of Josh Kaufman comes as GP looks to grow its nascent German investment capabilities
Phoenix Court Group raises USD 500m for four VC strategies
London-headquartered VC is raising for its LocalGlobe, Latitude, Solar and Basecamp funds
Kester nets 8x on Avania exit to Astorg
Medical device CRO is Astorg's first healthcare deal from its EUR 1.3bn Mid-Cap fund
GP Profile: Ergon hones in on long-term trends, ESG agenda
The European mid-market sponsor is eyeing growing and resilient businesses with its EUR 800m Fund V
LGT Capital closes first dedicated impact fund on USD 550m
Crown Impact will make co-investments, as well as primary and secondary fund investments
IK pauses Ampelmann auction amid macro concerns
Buyer interest dampened by Dutch offshore access systems developer's exposure to Russia
Gimv launches life sciences investment platform
Sponsor seeks to double portfolio and invest bigger tickets in drug development companies
Clearwater Multiples Heatmap: PE activity holds up amid war, inflation woes
Record levels of dry powder continue to bolster the resilience of the buyout market in Q1 2022
Main Capital on the road for debut growth fund with more fundraises in sight
New vintage of existing strategies and a healthcare-focused continuation fund are also on the agenda for the software-focused GP, according to founding partner and CEO Charly Zwemstra
Synergia plans EUR 200m Fund VI final close by end of 2022
GP is targeting family offices and entrepreneurs and aims to hold a EUR 150m first close by the end of June
Unigestion launches third Direct fund with EUR 1bn target
Strategy invests in mid-market companies alongside the GP's investment partner network
Forbion exceeds Growth Opportunities II target with EUR 470m first close
Biopharma GP sees growing demand for private capital amid IPO lull; gears up for EUR 600m hard-cap by summer end
LPs' net returns highest since financial crisis – Coller Capital
Secondaries specialistтs Summer 2022 Barometer shows that half of LPs want to increase their allocation to alternatives, with 91% still committing to PE first closes with incentives
Advent and Lanxess form EUR 3.7bn polymers JV with Royal DSM carve-out
Buyers pay EUR 3.7bn for DEM; the new unit has sales of over EUR 3bn and EBITDA of EUR 500m
Bain acquires majority stake in Naxicap-backed House of HR
Naxicap will continue its 10-year ownership period, retaining a minority stake in the HR services group
Goldman Sachs AM beats sponsors to buy Norgine
Buyer's PE arm competed with Bain and Cinven in the auction second round